“Test tube baby” is an informal term for a child conceived through in vitro fertilization, a process in which eggs and sperm are combined outside the body in a laboratory dish rather than inside the fallopian tube. The first baby born this way, Louise Brown, arrived in 1978, and the technique has gone from experimental to routine in the decades since. Success rates that were once in the single digits now approach 50% for women under 35, though outcomes vary widely depending on age and other factors.1Europe PMC. A History of Developments to Improve in vitro Fertilization The procedure involves several distinct stages, each with its own biology, timeline, and set of decisions.
Where the Name Comes From
“In vitro” is Latin for “in glass,” a reference to the glassware historically used in laboratories. The fertilization does not actually happen in a test tube; it takes place in a flat culture dish, sometimes called a Petri dish. But the phrase “test tube baby” caught on with the media after Louise Brown was born on July 25, 1978, at Oldham Hospital in England. She weighed about 5 pounds 12 ounces and was delivered by cesarean section at nearly 39 weeks.2PubMed Central. Assisted Reproductive Technology after the Birth of Louise Brown The birth made global headlines, and the nickname stuck even as the technology matured well beyond anything resembling a glass tube.
Ovarian Stimulation
In a natural menstrual cycle, one egg typically matures per month. IVF needs more than one to work with, so the process starts with hormone injections designed to push multiple follicles to develop at the same time. These medications are gonadotropins, synthetic versions of the hormones your body already uses to grow eggs. Daily injections usually continue for roughly 10 to 14 days, with dosing adjusted based on how the ovaries are responding.
During this phase, a clinic monitors follicle growth with ultrasound and blood tests every few days. When the follicles reach the right size, a “trigger shot” of human chorionic gonadotropin (hCG) or a similar drug signals the eggs to undergo their final maturation. Egg retrieval is then scheduled about 36 hours later. European guidelines on ovarian stimulation address dozens of variables at this stage, from which suppression protocol to use to how to minimize the risk of ovarian hyperstimulation.3PubMed Central. ESHRE guideline: ovarian stimulation for IVF/ICSI
Egg Retrieval
Egg collection is a short procedure, usually done under conscious sedation. A thin needle attached to an ultrasound probe is passed through the vaginal wall into each ovary, and the fluid inside each follicle is aspirated to capture the eggs. The transvaginal ultrasound-guided approach replaced older, more invasive methods like laparoscopy and has become the standard because it retrieves more follicles with fewer complications and higher pregnancy rates per cycle.4PubMed. Oocyte retrieval in an in vitro fertilization-embryo transfer program: comparison of four methods The whole retrieval typically takes 15 to 30 minutes, and most people go home the same day.
Studies on the fine points of retrieval, like whether flushing the follicle improves egg yield, have generally not shown a benefit. The procedure is considered safe when performed with low-pressure aspiration under ultrasound guidance.5PubMed. Optimal oocyte retrieval and embryo transfer techniques: where we are and how we got here
Sperm Collection and Male Factor Infertility
On the same day as egg retrieval, sperm is collected. For most couples this is straightforward. But when the male partner has no sperm in the ejaculate, a condition called azoospermia, surgical extraction may be necessary. Techniques include needle aspiration from the epididymis or testicle, and a more refined approach called microdissection testicular sperm extraction, where a surgeon uses an operative microscope to identify tubules likely to contain sperm. This microsurgical method achieves successful sperm retrieval in roughly two-thirds of men with non-obstructive azoospermia.6Fertility & Reproduction. Are Clinical Outcomes of Micro-TESE in Non-obstructive Azoospermic Men Affected by the Use of Fresh or Frozen Gametes? It is considered the best available option for these patients and works even in some genetic conditions that cause severely impaired sperm production.7PubMed Central. Surgical recovery of sperm in non-obstructive azoospermia
Fertilization in the Lab
Once eggs and sperm are in the laboratory, there are two main ways to bring them together. In conventional IVF, thousands of prepared sperm are placed alongside each egg in a dish and fertilization happens on its own. In intracytoplasmic sperm injection, a single sperm is injected directly into the egg using a microscopic needle. ICSI was originally developed for severe male infertility, but its use has expanded dramatically; many clinics now use it for most cycles regardless of sperm quality.8PubMed Central. Opportunities and Limits of Conventional IVF versus ICSI: It Is Time to Come off the Fence This trend is debated among embryologists, since conventional IVF is simpler and may naturally select healthier sperm, but ICSI removes the uncertainty of whether fertilization will happen at all.
Embryo Culture and Development
After fertilization, embryos are placed in carefully formulated culture media inside an incubator that maintains body temperature and tightly controlled levels of oxygen and carbon dioxide. Over the next three to six days, the fertilized egg divides repeatedly. In its earliest stages the embryo has a low metabolic rate and relies on simple fuels; after day three, when the embryo’s own genes switch on, its metabolism ramps up and it begins to use glucose and amino acids more actively.9PubMed. In vitro development and metabolism of the human embryo up to the blastocyst stage
By day five or six, a viable embryo has typically reached the blastocyst stage, a hollow ball of around 100 or more cells with an inner cell mass that will become the fetus and an outer layer that will form the placenta. Not every fertilized egg makes it this far. The ones that do are graded by an embryologist based on their appearance, and the best candidates are selected for transfer or freezing.
Embryo Transfer
Transfer is the moment the embryo goes back into the body. A thin catheter is threaded through the cervix, and the embryo is deposited in the uterus under ultrasound guidance. It takes only a few minutes and does not require sedation. The decision about whether to transfer a fresh embryo in the same cycle as stimulation or to freeze all embryos and transfer one in a later cycle has become a major strategic question in modern IVF. Frozen embryo transfer cycles use hormone replacement to prepare the uterine lining on a more controlled timeline.10Human Reproduction. P-470 Endometrial immune cell profiles differ during fresh vs. frozen embryo transfer cycles: insights into the window of implantation
The question of how many embryos to transfer matters enormously. Transferring two embryos raises the chance of twins, which carry higher risks of preterm delivery and complications for both mother and babies. Research shows that elective single-embryo transfer actually produces a higher live birth rate per transfer than putting back two embryos at once, and when a second frozen transfer is counted as part of the same cycle’s effort, the cumulative success rate climbs further while costs stay lower.11PubMed Central. Outcomes and cost analysis of single-embryo transfer versus double-embryo transfer Most guidelines now recommend single-embryo transfer for patients with a good prognosis.
How Age Shapes Success
Age is the single biggest predictor of whether IVF will work, and this is almost entirely about egg quality, not uterine health. Among women aged 30 to 35, about a third of cycles result in a live birth. By the early 40s, that figure drops to roughly 15%, and by 42 or 43 it falls to around 6%.12PubMed. A retrospective study of the effect of increasing age on success rates of assisted reproductive technology The decline is steep and starts earlier than many people expect.
A reasonable question is whether this age effect is all about the egg or also about the uterus. A meta-analysis that looked at transfers of chromosomally normal embryos still found higher live birth rates in women under 35 compared with older groups, with a consistent gradient as age increased.13PubMed. Does maternal age affect assisted reproduction technology success rates after euploid embryo transfer? A systematic review and meta-analysis That finding suggests age affects the uterine environment too, not just the eggs. But the effect is much smaller than the impact of egg quality itself, which is why donor eggs from younger women can dramatically boost pregnancy rates in older recipients.
Preimplantation Genetic Testing
Before transfer, clinics can biopsy a few cells from the outer layer of the blastocyst and test them for chromosomal abnormalities. This is called preimplantation genetic testing for aneuploidies. The idea is that transferring only embryos with the right number of chromosomes should raise pregnancy rates and lower miscarriage risk. In practice, the evidence is more mixed than many patients realize. Some studies support the approach, while others have found no clear improvement in live birth rates, particularly for women who have fewer embryos to test. When there are only a small number of embryos to work with, testing and discarding some could actually reduce a patient’s overall chance of having a baby.14PubMed Central. Preimplantation genetic testing: A narrative review The number and quality of available embryos should factor into the decision about whether genetic testing is worthwhile.
Ovarian Hyperstimulation Syndrome
The most distinctive medical risk of IVF is ovarian hyperstimulation syndrome. When the ovaries over-respond to stimulation drugs, they swell with fluid-filled cysts and release substances that cause blood vessels to leak fluid into the abdomen and sometimes the lungs. Mild cases involve bloating and discomfort. Severe cases can lead to blood clots, kidney problems, and hospitalization.15PubMed Central. Ovarian hyperstimulation syndrome The condition is triggered by hCG, the hormone used to mature the eggs before retrieval. Women with polycystic ovary syndrome are at higher risk because their ovaries tend to produce more follicles.
Prevention strategies have improved considerably. Using a different class of suppression drug (called an antagonist protocol) lowers the risk compared with older approaches. In antagonist cycles, clinics can substitute a different trigger medication in place of hCG, which dramatically reduces the chance of hyperstimulation. Freezing all embryos and delaying transfer until a later cycle also removes the additional hCG exposure that a pregnancy would add.16PubMed Central. Ovarian hyperstimulation syndrome: pathophysiology and prevention These shifts in clinical practice have made severe cases less common than they were a decade or two ago.
The Emotional Side
IVF is physically demanding, but the psychological toll can be equally heavy. Anxiety and depressive symptoms tend to increase as treatment progresses, peaking during the waiting periods when the outcome is uncertain. Women consistently report higher psychological distress than their partners across most stages of the cycle.17PubMed Central. The Psychological Impact of In Vitro Fertilization (IVF): A Gender Systematic Review This is not just about injections and clinic visits; it is the weight of hope, financial stress, and the very real possibility of failure in something deeply personal.
Research on psychological support during IVF has found that interventions like cognitive behavioral therapy and mind-body programs can reduce anxiety and may improve pregnancy rates and relationship satisfaction. However, none of the studied interventions have been shown to relieve depression or the broader stress of treatment reliably.18PubMed Central. The effects of psychosocial interventions on the mental health, pregnancy rates, and marital function of infertile couples undergoing in vitro fertilization: a systematic review Many clinics now offer or refer patients to mental health support, but it remains underutilized.
Long-Term Health of IVF-Conceived Children
With millions of people now alive who were conceived through IVF, long-term follow-up data is growing. The overall picture is reassuring: most IVF children develop normally and have no major health problems through childhood and adolescence.19PubMed Central. The longer-term effects of IVF on offspring from childhood to adolescence Some studies have flagged subtle differences in blood pressure and cardiovascular markers in IVF-conceived children compared with naturally conceived peers.20PubMed. Long-term outcomes for children conceived by assisted reproductive technology Whether these translate into meaningful clinical problems in adulthood is not yet clear, since the oldest IVF cohort is only in their mid-40s.
Research has also identified epigenetic changes in some IVF offspring, meaning small modifications to how genes are expressed without changes to the DNA sequence itself. Some investigators have reported associations with conditions like asthma, metabolic syndrome, and neurodevelopmental differences, though the absolute increases in risk are small and difficult to separate from the effects of the underlying infertility that led to IVF in the first place.21PubMed Central. Long-term health risk of offspring born from assisted reproductive technologies Disentangling the effects of the IVF procedure from the effects of parental subfertility is one of the hardest problems in this field.
What Surplus Embryos Mean for Families
Many IVF cycles produce more viable embryos than a couple needs. These are frozen for possible future use, but when families are complete, the question of what to do with leftover embryos becomes deeply personal. Options typically include keeping them frozen, donating them to another family, donating them to research, or having them discarded. Studies find that many people struggle with this decision for years. In one Israeli study, about 60% of patients with frozen embryos simply did not respond to requests for a disposition decision, leaving embryos in indefinite storage.22PubMed. Unmet communication needs and moral work in the disposition decision concerning surplus frozen embryos: The perspectives of IVF users
The emotional weight comes partly from ambiguity about what an embryo represents. Some people view frozen embryos as potential children; others see them more as biological material with the potential for further development. The tension between these views makes every disposition option feel loaded. Legal frameworks vary widely by country; some allow embryo donation to other couples, some restrict it, and policies on storage limits and research use differ across jurisdictions.23Human Reproduction. Decisions for the fate of frozen embryos: Fresh insights into patients’ thinking and their rationales for donating or discarding embryos
Cost and Access Around the World
IVF is expensive, and that expense is one of the biggest barriers to who actually gets treated. In the United States, a single cycle can cost upward of $15,000 to $20,000 including medications, and insurance coverage is inconsistent. Some states mandate coverage; others do not. Many patients are unaware of what their insurance does or does not pay for, which discourages them from even starting treatment.24PubMed Central. Inequity of Access: Scoping the Barriers to Assisted Reproductive Technologies
In low- and middle-income countries, the financial barrier is even steeper. A systematic review found that the direct medical costs patients pay for one cycle of treatment often exceed the country’s per-capita income. Even in nations with some government financing, patients spent roughly half their annual income on a single cycle. In countries without financing mechanisms, the cost was more than double the average annual income.25Human Reproduction Open. Financial costs of assisted reproductive technology for patients in low- and middle-income countries: a systematic review The desire for children is strong enough that many families take on catastrophic debt to pay for treatment, creating what researchers have called a “medical and social poverty trap.”
In Vitro Maturation and Reduced Stimulation
Not everyone is a good candidate for the standard stimulation protocol. In vitro maturation is a technique where immature eggs are collected from the ovaries with little or no hormonal stimulation and then matured in the lab before fertilization. It is particularly useful for women with polycystic ovary syndrome, who are at high risk for ovarian hyperstimulation, and for cancer patients who need to preserve fertility quickly before starting chemotherapy.26PubMed Central. In vitro maturation (IVM) of human immature oocytes: is it still relevant? The technique is now classified as non-experimental, though success rates have historically been lower than conventional IVF.
Newer laboratory approaches are working to close that gap. Researchers have developed systems that mimic the gradual hormonal signaling eggs experience inside the body, slowing down the maturation process in the dish rather than letting it rush forward. In animal models, these systems have substantially improved embryo quality and pregnancy rates compared with standard lab maturation.27Human Reproduction. Simulated physiological oocyte maturation (SPOM): a novel in vitro maturation system that substantially improves embryo yield and pregnancy outcomes Adapting them for human clinical use is an active area of research.
Gestational Surrogacy
When a person cannot carry a pregnancy, IVF embryos can be transferred into a gestational carrier. In this arrangement, the surrogate has no genetic connection to the child; the embryo is created from the intended parents’ eggs and sperm (or from donors). National data in the United States has shown that gestational carrier cycles tend to have higher implantation and live birth rates than standard IVF cycles, likely because surrogates are pre-screened for uterine health and are generally younger and without fertility problems.28PubMed Central. Trends and outcomes of gestational surrogacy in the United States However, rates of multiple births and preterm delivery are also higher in these cycles, a risk that can be reduced by transferring a single embryo.
An emerging area of research concerns the immunological relationship between the surrogate and the embryo. When the embryo shares no genetic material with the carrier, the pregnancy appears to carry higher medical risks, including higher rates of preeclampsia and other complications, compared to pregnancies where the carrier is genetically related to the embryo. Some researchers have proposed that immunological matching, similar in concept to what is done for organ transplants, could improve outcomes for surrogates.29PubMed. Egg donation and gestational surrogacy: Pregnancy is riskier with an unrelated embryo
Artificial Intelligence in Embryo Selection
Embryo grading has traditionally depended on a trained embryologist looking through a microscope and assessing shape, symmetry, and development pace. This is inherently subjective, and two skilled embryologists can disagree on which embryo in a cohort looks best. Time-lapse imaging, where a camera inside the incubator records the embryo’s development continuously rather than checking it at set intervals, has added more data points. But interpreting those images still relies heavily on human judgment.
Artificial intelligence models are now being trained to analyze time-lapse video and predict which embryos are most likely to implant and which are chromosomally normal. Deep-learning systems that use the full developmental video alongside maternal age have shown promise as non-invasive decision-support tools, potentially supplementing or replacing some of the subjectivity in traditional grading.30Human Reproduction. AI prediction models based on time-lapse imaging for good embryos with implantation potential and euploidy The appeal is obvious: better embryo selection could mean higher pregnancy rates from fewer transfers and less reliance on invasive genetic biopsies. Whether these tools deliver on that promise in large-scale clinical practice remains to be seen, but integration of AI into embryology labs is accelerating.31PubMed Central. Use of time-lapse technology and artificial intelligence in the embryology laboratory: an updated review